These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2967303)

  • 21. [A case of apolipoprotein E3 deficiency (E2/2 phenotype) associated with renovascular hypertension and atherosclerosis obliterans].
    Chiao S; Nozaki S; Hara H; Nakajima T; Kameda K; Kubo M; Tokunaga K; Hirobe K; Matsuzawa Y; Tarui S
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1805-10. PubMed ID: 6533213
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.
    Feussner G; Wagner A; Kohl B; Ziegler R
    Clin Investig; 1993 May; 71(5):362-6. PubMed ID: 8508005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136-->Ser) variant in multigenerational pedigree studies.
    Pocovi M; Cenarro A; Civeira F; Myers RH; Casao E; Esteban M; Ordovas JM
    Atherosclerosis; 1996 Apr; 122(1):33-46. PubMed ID: 8724110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathognomonic Palmar Crease Xanthomas of Apolipoprotein E2 Homozygosity-Familial Dysbetalipoproteinemia.
    Rothschild M; Duhon G; Riaz R; Jetty V; Goldenberg N; Glueck CJ; Wang P
    JAMA Dermatol; 2016 Nov; 152(11):1275-1276. PubMed ID: 27603268
    [No Abstract]   [Full Text] [Related]  

  • 26. Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan.
    Eto M; Saito M; Nakata H; Iwashima Y; Watanabe K; Ikoda A; Kaku K
    Clin Genet; 2002 Jun; 61(6):416-22. PubMed ID: 12121348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R
    Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary changes of apolipoproteins B and E].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Antignano A; Sifola C; Scala R
    Clin Ter; 1994 Jun; 144(6):527-37. PubMed ID: 8001338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperlipoproteinemia type III: genetic basis and environmental factors, diagnosis, and treatment].
    Pocoví M; Garcés C; Casao E; Cenarro A; Civeira F
    Rev Clin Esp; 1992 Nov; 191(8):444-50. PubMed ID: 1488520
    [No Abstract]   [Full Text] [Related]  

  • 32. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of type III hyperlipoproteinemia in Germany.
    Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
    Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of variant apolipoprotein E by isoelectric focusing and restriction isotyping in a patient with type III hyperlipoproteinemia.
    Nassar BA; McPherson R; Lamothe EM; al-Sultan AI; Zhang ZJ; Rosenblatt DS
    Clin Chem; 1991 Jul; 37(7):1308. PubMed ID: 1677318
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial type V hyperlipoproteinaemia in identical twins homozygous for apoliprotein variant E2: report.
    Nye ER; Sutherland WH; Janus ED
    N Z Med J; 1986 Mar; 99(797):146-9. PubMed ID: 3457291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation and mode of inheritance of apolipoprotein E3-Leiden.
    Havekes L; Utermann G; de Knijff P; Klasen E
    Adv Exp Med Biol; 1987; 210():41-5. PubMed ID: 3591555
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
    Karube M; Nakabayashi K; Fujioka Y; Yoshihara K; Yamada A; Matsunaga A; Saito T
    Clin Exp Nephrol; 2007 Jun; 11(2):174-179. PubMed ID: 17593519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.
    Feussner G; Ziegler R
    Hum Genet; 1991 Jan; 86(3):326-8. PubMed ID: 1997392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.